Literature DB >> 26891227

Frontal Lobe Degeneration in Adults with Down Syndrome and Alzheimer's Disease: A Review.

Luciana Mascarenhas Fonseca1, Juliana Emy Yokomizo, Cassio Machado Bottino, Daniel Fuentes.   

Abstract

BACKGROUND: There is a proven link between Down syndrome and the early development of the neuropathological features of Alzheimer's disease (AD). Changes in the personality and behavior of adults with Down syndrome might indicate the early stages of dementia or of frontotemporal lobar degeneration. The objective of this study was to investigate the executive functions and changes in behavior associated with frontal lobe degeneration in individuals with Down syndrome who develop AD. We conducted a systematic review selecting studies employing cognitive assessments.
SUMMARY: We identified few studies using objective measurements to determine whether cognitive aspects associated with the frontal lobe correlate with dementia in this population. We observed a tendency toward such correlations. KEY MESSAGES: There is a need for further studies in which objective measures of cognitive and behavioral factors are evaluated together with data related to brain function and morphology.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 26891227     DOI: 10.1159/000442941

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  10 in total

Review 1.  Exosome release and cargo in Down syndrome.

Authors:  Eric D Hamlett; Angela LaRosa; Elliott J Mufson; Juan Fortea; Aurélie Ledreux; Ann-Charlotte Granholm
Journal:  Dev Neurobiol       Date:  2019-08-06       Impact factor: 3.964

2.  Neurogenesis and neuronal differentiation in the postnatal frontal cortex in Down syndrome.

Authors:  Emma C Utagawa; David G Moreno; Kristian T Schafernak; Nicoleta C Arva; Michael H Malek-Ahmadi; Elliott J Mufson; Sylvia E Perez
Journal:  Acta Neuropathol Commun       Date:  2022-06-08       Impact factor: 7.578

3.  Microstate Changes Associated With Alzheimer's Disease in Persons With Down Syndrome.

Authors:  Christian Sandøe Musaeus; Lise Cronberg Salem; Troels Wesenberg Kjaer; Gunhild Waldemar
Journal:  Front Neurosci       Date:  2019-11-28       Impact factor: 4.677

4.  Validity Evidences of the Prefrontal Symptoms Inventory for the Elderly Brazilian Population.

Authors:  Olívia Dayse Leite Ferreira; Leopoldo Nelson Fernandes Barbosa; João Carlos Alchieri
Journal:  Clinics (Sao Paulo)       Date:  2020-12-09       Impact factor: 2.365

Review 5.  Neurological Manifestations of Wilson's Disease: Pathophysiology and Localization of Each Component.

Authors:  Juan Fernando Ortiz; Álvaro Morillo Cox; Willians Tambo; Noha Eskander; Martín Wirth; Margarita Valdez; Maria Niño
Journal:  Cureus       Date:  2020-11-16

6.  Cognitive Function during the Prodromal Stage of Alzheimer's Disease in Down Syndrome: Comparing Models.

Authors:  Christy L Hom; Katharine A Kirby; Joni Ricks-Oddie; David B Keator; Sharon J Krinsky-McHale; Margaret B Pulsifer; Herminia Diana Rosas; Florence Lai; Nicole Schupf; Ira T Lott; Wayne Silverman
Journal:  Brain Sci       Date:  2021-09-16

Review 7.  Structural Connectivity in Down Syndrome and Alzheimer's Disease.

Authors:  Fedal Saini; Flavio Dell'Acqua; Andre Strydom
Journal:  Front Neurosci       Date:  2022-07-22       Impact factor: 5.152

8.  The validity and reliability of the CAMDEX-DS for assessing dementia in adults with Down syndrome in Brazil.

Authors:  Luciana M Fonseca; Glenda G Haddad; Guilherme P Mattar; Melaine C de Oliveira; Sharon S Simon; Laura M Guilhoto; Geraldo F Busatto; Shahid Zaman; Anthony J Holland; Marcelo Q Hoexter; Cassio M Bottino
Journal:  Braz J Psychiatry       Date:  2018-10-22       Impact factor: 2.697

9.  Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.

Authors:  L Lemoine; A Ledreux; E J Mufson; S E Perez; G Simic; E Doran; I Lott; S Carroll; K Bharani; S Thomas; A Gilmore; E D Hamlett; A Nordberg; A C Granholm
Journal:  Mol Neurodegener       Date:  2020-11-23       Impact factor: 14.195

Review 10.  Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.

Authors:  Natalie Neale; Concepcion Padilla; Luciana Mascarenhas Fonseca; Tony Holland; Shahid Zaman
Journal:  Neuroimage Clin       Date:  2017-11-06       Impact factor: 4.881

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.